iRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $165.00 by Analysts at Needham & Company LLC

Posted by George Bondi on Nov 7th, 2026

iRhythm Technologies (NASDAQ:IRTC – Free Report) had its price target reduced by Needham & Company LLC from $194.00 to $165.00 in a research report report published on Friday, MarketBeat reports. They currently have a buy rating on the stock.

Other research analysts have also issued reports about the company. Stephens started coverage on iRhythm Technologies in a report on Thursday, July 23rd. They issued an “overweight” rating and a $160.00 target price for the company. Weiss Ratings upgraded iRhythm Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, October 27th. Piper Sandler began coverage on iRhythm Technologies in a research report on Friday, October 16th. They issued an “overweight” rating and a $160.00 price target on the stock. Truist Financial increased their price target on iRhythm Technologies from $160.00 to $168.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Finally, Canaccord Genuity Group lifted their price objective on iRhythm Technologies from $196.00 to $206.00 and gave the company a “buy” rating in a research note on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, iRhythm Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.07.

View Our Latest Research Report on IRTC

iRhythm Technologies Trading Down 30.7%

NASDAQ:IRTC traded down $39.97 on Friday, reaching $90.22. 5,666,907 shares of the company’s stock were exchanged, compared to its average volume of 508,477. The firm has a market capitalization of $2.97 billion, a price-to-earnings ratio of -77.11 and a beta of 1.39. iRhythm Technologies has a 52-week low of $86.30 and a 52-week high of $192.47. The company has a quick ratio of 3.74, a current ratio of 3.86 and a debt-to-equity ratio of 3.50. The business has a fifty day moving average of $114.95 and a 200-day moving average of $121.69.

iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.82 EPS for the quarter, beating the consensus estimate of $0.02 by $0.80. iRhythm Technologies had a negative net margin of 1.69% and a positive return on equity of 10.11%. The business had revenue of $221.59 million during the quarter, compared to analyst estimates of $222.23 million. During the same quarter last year, the firm posted ($0.06) earnings per share. The business’s revenue for the quarter was up 14.9% compared to the same quarter last year. As a group, analysts expect that iRhythm Technologies will post 0.54 earnings per share for the current year.

Hedge Funds Weigh In On iRhythm Technologies

Large investors have recently bought and sold shares of the business. Versant Capital Management Inc lifted its holdings in iRhythm Technologies by 123.2% during the 3rd quarter. Versant Capital Management Inc now owns 221 shares of the company’s stock worth $25,000 after buying an additional 122 shares during the last quarter. Covestor Ltd increased its holdings in shares of iRhythm Technologies by 44.8% in the 3rd quarter. Covestor Ltd now owns 417 shares of the company’s stock valued at $47,000 after acquiring an additional 129 shares during the last quarter. Harbor Investment Advisory LLC purchased a new position in shares of iRhythm Technologies in the 2nd quarter valued at about $50,000. Assetmark Inc. raised its position in shares of iRhythm Technologies by 30.1% during the 1st quarter. Assetmark Inc. now owns 821 shares of the company’s stock worth $97,000 after acquiring an additional 190 shares in the last quarter. Finally, Sterling Capital Management LLC raised its position in shares of iRhythm Technologies by 842.2% during the 3rd quarter. Sterling Capital Management LLC now owns 1,093 shares of the company’s stock worth $124,000 after acquiring an additional 977 shares in the last quarter.

Trending Headlines about iRhythm Technologies

Here are the key news stories impacting iRhythm Technologies this week:

Positive Sentiment: iRhythm reported third-quarter earnings of $0.82 per share, above the $0.02 consensus estimate, and revenue grew 14.9% year over year. Third-quarter 2026 financial results
Positive Sentiment: Despite reducing targets, Needham and BTIG retained Buy ratings, while Wells Fargo and Piper Sandler maintained Overweight ratings—indicating continued optimism among those firms. Needham analyst ratings
Neutral Sentiment: The company announced plans to participate in upcoming investor conferences; no new financial or operating outlook was included in the announcement. Investor conference announcement
Negative Sentiment: Revenue of $221.6 million narrowly missed the $222.2 million estimate. The small shortfall may have weighed on sentiment despite the EPS beat. Quarterly revenue results
Negative Sentiment: Analysts cut targets: Wells Fargo to $135 from $150, Piper Sandler to $150 from $160, Needham to $165 from $194, and BTIG to $170 from $185. Citigroup also downgraded IRTC from Buy to Neutral and lowered its target to $124 from $157. These revisions add to concerns about the outlook, even though most firms still see potential upside from the current share price. Citigroup analyst rating

About iRhythm Technologies

(Get Free Report)

iRhythm Technologies, Inc is a digital health company focused on the diagnosis and management of cardiac arrhythmias. The company provides ambulatory cardiac monitoring services that enable physicians to evaluate patients for conditions such as atrial fibrillation and other irregular heart rhythms.

Its principal offering is the Zio platform, which combines wearable electrocardiogram (ECG) monitoring devices with cloud-based data analysis and physician reports. Products in the platform include the Zio XT, an extended-wear monitor, and the Zio AT, which provides near-real-time monitoring capabilities.